Raj K. Rajpal, MD
Show Description +
Raj K. Rajpal, MD, reviews the path of CXL development from 2003 to present and discusses what's potentially ahead, including a new CXL clinical trial launching in the United States. The study is designed to look at formulations of riboflavin that can better penetrate the epithelium and an expanded role for oxygen.
Posted: 6/17/2018
Raj K. Rajpal, MD
Raj K. Rajpal, MD, reviews the path of CXL development from 2003 to present and discusses what's potentially ahead, including a new CXL clinical trial launching in the United States. The study is designed to look at formulations of riboflavin that can better penetrate the epithelium and an expanded role for oxygen.
Posted: 6/17/2018
Bryn Mawr Communications, LLC, and Eyetube.net are not affiliated with the official program of WOC: 2018.
Please log in to leave a comment.